- Home
- FNWB vs DERM Comparison
FNWB vs DERM Comparison
Compare FNWB & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- DERM
- Stock Information
- Founded
- FNWB 1923
- DERM 2014
- Country
- FNWB United States
- DERM United States
- Employees
- FNWB N/A
- DERM N/A
- Industry
- FNWB Banks
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- DERM Health Care
- Exchange
- FNWB Nasdaq
- DERM Nasdaq
- Market Cap
- FNWB 89.9M
- DERM 87.4M
- IPO Year
- FNWB 2015
- DERM 2021
- Fundamental
- Price
- FNWB $10.93
- DERM $3.74
- Analyst Decision
- FNWB Hold
- DERM Strong Buy
- Analyst Count
- FNWB 1
- DERM 3
- Target Price
- FNWB $11.00
- DERM $9.50
- AVG Volume (30 Days)
- FNWB 15.9K
- DERM 61.7K
- Earning Date
- FNWB 01-31-2025
- DERM 11-12-2024
- Dividend Yield
- FNWB 2.54%
- DERM N/A
- EPS Growth
- FNWB N/A
- DERM N/A
- EPS
- FNWB N/A
- DERM N/A
- Revenue
- FNWB $50,768,000.00
- DERM $57,771,000.00
- Revenue This Year
- FNWB N/A
- DERM N/A
- Revenue Next Year
- FNWB $11.49
- DERM $36.49
- P/E Ratio
- FNWB N/A
- DERM N/A
- Revenue Growth
- FNWB N/A
- DERM N/A
- 52 Week Low
- FNWB $8.91
- DERM $2.85
- 52 Week High
- FNWB $16.00
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- FNWB 63.58
- DERM 32.80
- Support Level
- FNWB $9.96
- DERM $3.54
- Resistance Level
- FNWB $10.31
- DERM $3.99
- Average True Range (ATR)
- FNWB 0.23
- DERM 0.35
- MACD
- FNWB 0.11
- DERM 0.00
- Stochastic Oscillator
- FNWB 85.09
- DERM 21.28
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.